Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Dutogliptin

Generic Name: Dutogliptin

Drug Type: Small Molecule

Chemical Formula: C_₁₀H_₂₀BN_₃O_₃

CAS Number: 852329-66-9

Unique Ingredient Identifier: 38EAO245ZX

Overview

Dutogliptin has been investigated for the treatment of Diabetes Mellitus, Type II.

Background

Dutogliptin has been investigated for the treatment of Diabetes Mellitus, Type II.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction

Phase 3

Not yet recruiting

Posted: 2023/05/31

Sponsor:Recardio, Inc.

ID:NCT05881382

Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial Infarction

Phase 2

Completed

Posted: 2018/04/03

Sponsor:Recardio, Inc.

ID:NCT03486080

Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

Phase 2

Terminated

Posted: 2010/04/12

Sponsor:

Phenomix

ID:NCT01101945

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone

Phase 3

Terminated

Posted: 2010/03/19

Sponsor:

Forest Laboratories

ID:NCT01089790

Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

Phase 3

Terminated

Posted: 2009/10/20

Sponsor:

Phenomix

ID:NCT00998686

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy